| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA698562 | F | Cytotoxic activity against human colon cancer cell line | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 2. | ALA698563 | F | In vivo activity as average tumor weight on day 22/average tumor weight in control group on day 22*100; drug administered intra venously | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA698564 | F | In vivo activity as average tumor weight on day 22/average tumor weight in control group on day 22*100; drug administered intraperitoneal | Homo sapiens | 11 | organism-based format | Scientific Literature | ||
| 4. | ALA698565 | F | In vivo activity as average tumor weight on day 22/average tumor weight in control group on day 22*100; drug administered per oral | Homo sapiens | 3 | organism-based format | Scientific Literature | ||
| 5. | ALA698566 | F | In vivo activity as average tumor volume on day 9/average tumor volume on day 1 drug administered per oral | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA698567 | F | In vivo activity as average tumor volume on day 9/average tumor volume on day 1; drug administered intra venously | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA698568 | F | In vivo activity as average tumor volume on day 9/average tumor volume on day 1; drug administered intraperitoneal | Homo sapiens | 11 | organism-based format | Scientific Literature | ||
| 8. | ALA878460 | F | In vivo activity as average tumor volume on day 9/average tumor volume on day 1; drug administered per oral | Homo sapiens | 2 | organism-based format | Scientific Literature | ||
| 9. | ALA4738934 | F | Growth inhibition of human colon cancer cell line incubated for 48 hrs by sulforhodamine B assay | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 10. | ALA4823208 | F | Cytotoxicity against patient-derived human colon cancer organoids assessed as reduction of crypt size and disruption of intact organoid structure at 10 uM measured after 5 days by Celltiter-glo luminescent assay relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA5030947 | F | Antitumour activity against human colorectal cancer cells xenografted in BALB/c mouse assessed as tumour suppression at 50 mg/kg, ip administered once every 3 days for 3 weeks | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 12. | ALA5030949 | F | Synergistic antitumour activity against human colorectal cancer cells xenografted in BALB/c mouse assessed as reduction in tumour size at 30 mg/kg, ip administered once every 3 days for 3 weeks in presence of 10 mg/kg 5-FU | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA5215377 | F | Anticancer activity against human Colon carcinoma cell assessed as cell growth inhibition | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 14. | ALA5242166 | F | Cytotoxicity against human Colon cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!